MET exon 14 skipping is overexpressed in an allele-specific manner in lung adenocarcinoma primary samples.

exon 14 skipping ( ) is a well-characterized oncogene in the Ras-MAPK pathway driving lung adenocarcinoma (LUAD). Previous studies on revealed this aberrantly spliced oncogene is expressed in LUAD primary samples and is associated with heterozygous somatic mutations and deletions near exon 14 splice sites. Upon further examination of DNA and RNA sequencing data from primary samples, we highlight that is overexpressed in an allele-specific manner. These data suggest that dose-dependence of may be critical to oncogenesis.